Expectations For Plain Language Summaries Continue To Evolve

As global transparency standards continue to evolve, Plain Language Summaries (PLS) have become an essential component of clinical trial disclosure. Designed to make complex clinical data understandable to non-specialist audiences, PLS play a crucial role in building public trust, supporting patient engagement, and meeting expanding global regulatory requirements.

This session explores the growing importance of PLS as a regulatory and ethical requirement in clinical research. You’ll gain a clear understanding of both protocol and results summaries, with practical guidance on how to craft high-quality, compliant PLS that align with the latest global expectations.

Learn about emerging regulatory trends, evolving agency guidance, and proven best practices for global PLS implementation — including how to integrate plain language principles into your organization’s transparency and disclosure processes.